Despite the fact that the mechanisms by which anti-P antibodies cause memory and cognitive impairment are not fully understood, these results are evidence of the potentially neuropathogenic nature of anti-P antibodies and also represent a molecular target for future exploration of neuropsychiatric disorders of NPSLE and other psychiatric diseases. Here, OCA2 is linked to psychiatric disorder.